AMGN

NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$418.13

+3.52 (+0.85%)

As of Sep 28, 9:30 PM ET ·

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 20 47%

Hold 20 47%

Sell 3 7%

Price Target

Analyst Price Target -54.4% upside

Low Target $141.50

Average Target $190.87

High Target $279.75

Current Price $418.13

Current
$418.13

Target
$190.87

$141.50 $190.87 avg $279.75

Scenario Analysis

Bear Case

$141.50

-66.2%

Low target

Base Case

$190.87

-54.4%

Avg target

Bull Case

$279.75

+-33.1%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$447.03

-6.5% from high

52-Week Low

$269.77

+55.0% from low

50-Day SMA

$340.27

+22.9% vs SMA

200-Day SMA

$306.48

+36.4% vs SMA

RSI (14)

67.1

Neutral

Target vs 52W High

$190.87

-57.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%